In reply

摘要

If benefits were obtained on only some cognitive outcomes, if effect sizes were small, and if the benefits did not survive correction against a type I error, the cognitive promise of ARBs may be small and clinically irrelevant. Consider that previous studies found inconsistent cognitive benefits in elderly subjects receiving ARBs, with low to moderate effect sizes when soft end points were addressed2 and no benefits for hard end points.